Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · IEX Real-Time Price · USD
3.250
-0.080 (-2.40%)
At close: Jul 19, 2024, 4:00 PM
3.170
-0.080 (-2.46%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Heron Therapeutics Employees
Heron Therapeutics had 126 employees as of December 31, 2023. The number of employees decreased by 77 or -37.93% compared to the previous year.
Employees
126
Change (1Y)
-77
Growth (1Y)
-37.93%
Revenue / Employee
$1,048,405
Profits / Employee
-$642,468
Market Cap
489.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sharecare | 3,352 |
Treace Medical Concepts | 516 |
Jin Medical International | 245 |
biote | 194 |
COMPASS Pathways | 186 |
Fate Therapeutics | 181 |
Y-mAbs Therapeutics | 100 |
Fulcrum Therapeutics | 76 |
HRTX News
- 7 days ago - Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System - PRNewsWire
- 20 days ago - Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") - PRNewsWire
- 7 weeks ago - Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") - PRNewsWire
- 2 months ago - Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates - PRNewsWire
- 3 months ago - Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - PRNewsWire
- 3 months ago - Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City - PRNewsWire
- 4 months ago - Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 months ago - Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates - PRNewsWire